1
|
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response.
|
Nat Med
|
2006
|
13.51
|
2
|
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
|
N Engl J Med
|
2011
|
11.01
|
3
|
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways.
|
Nature
|
2006
|
10.95
|
4
|
Progress and problems with the use of viral vectors for gene therapy.
|
Nat Rev Genet
|
2003
|
6.95
|
5
|
RNA interference in adult mice.
|
Nature
|
2002
|
5.33
|
6
|
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice.
|
Nat Biotechnol
|
2007
|
5.04
|
7
|
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.
|
Mol Ther
|
2006
|
4.64
|
8
|
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B.
|
Blood
|
2002
|
4.60
|
9
|
A nonviral minicircle vector for deriving human iPS cells.
|
Nat Methods
|
2010
|
4.42
|
10
|
In vitro and in vivo gene therapy vector evolution via multispecies interbreeding and retargeting of adeno-associated viruses.
|
J Virol
|
2008
|
3.79
|
11
|
Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.
|
Nat Struct Mol Biol
|
2009
|
3.70
|
12
|
Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors.
|
J Virol
|
2004
|
3.65
|
13
|
Human tRNA-derived small RNAs in the global regulation of RNA silencing.
|
RNA
|
2010
|
3.40
|
14
|
Sarcoma derived from cultured mesenchymal stem cells.
|
Stem Cells
|
2006
|
3.40
|
15
|
Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice.
|
J Virol
|
2005
|
3.28
|
16
|
Inhibition of hepatitis B virus in mice by RNA interference.
|
Nat Biotechnol
|
2003
|
3.15
|
17
|
High-resolution genome-wide mapping of transposon integration in mammals.
|
Mol Cell Biol
|
2005
|
3.10
|
18
|
Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo.
|
Mol Ther
|
2003
|
2.95
|
19
|
The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9.
|
J Virol
|
2006
|
2.94
|
20
|
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
|
N Engl J Med
|
2014
|
2.92
|
21
|
Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration.
|
J Clin Invest
|
2011
|
2.83
|
22
|
AAV serotype 2 vectors preferentially integrate into active genes in mice.
|
Nat Genet
|
2003
|
2.81
|
23
|
Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy.
|
Blood
|
2003
|
2.74
|
24
|
Distinct pathways of genomic progression to benign and malignant tumors of the liver.
|
Proc Natl Acad Sci U S A
|
2007
|
2.56
|
25
|
Site-specific genomic integration produces therapeutic Factor IX levels in mice.
|
Nat Biotechnol
|
2002
|
2.54
|
26
|
Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6.
|
Mol Ther
|
2003
|
2.49
|
27
|
In vivo activity of nuclease-resistant siRNAs.
|
RNA
|
2004
|
2.33
|
28
|
Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
|
Nat Biotechnol
|
2002
|
2.31
|
29
|
Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver.
|
J Virol
|
2005
|
2.09
|
30
|
Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.
|
Hum Gene Ther
|
2005
|
2.06
|
31
|
Expression of shRNA from a tissue-specific pol II promoter is an effective and safe RNAi therapeutic.
|
Mol Ther
|
2008
|
2.01
|
32
|
Mutational analysis of the N-terminal DNA-binding domain of sleeping beauty transposase: critical residues for DNA binding and hyperactivity in mammalian cells.
|
Mol Cell Biol
|
2004
|
1.97
|
33
|
Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver.
|
J Clin Invest
|
2010
|
1.91
|
34
|
The loop position of shRNAs and pre-miRNAs is critical for the accuracy of dicer processing in vivo.
|
Cell
|
2012
|
1.84
|
35
|
Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.
|
Circ Res
|
2012
|
1.84
|
36
|
Site-directed transposon integration in human cells.
|
Nucleic Acids Res
|
2007
|
1.74
|
37
|
A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction.
|
J Virol
|
2002
|
1.71
|
38
|
Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver.
|
Mol Ther
|
2007
|
1.51
|
39
|
Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice.
|
Mol Ther
|
2002
|
1.51
|
40
|
Histone modifications are associated with the persistence or silencing of vector-mediated transgene expression in vivo.
|
Mol Ther
|
2007
|
1.51
|
41
|
Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation.
|
Mol Ther
|
2008
|
1.49
|
42
|
Novel minicircle vector for gene therapy in murine myocardial infarction.
|
Circulation
|
2009
|
1.45
|
43
|
Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
|
Mol Ther
|
2003
|
1.42
|
44
|
Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.
|
Hepatology
|
2010
|
1.41
|
45
|
Combinatorial RNAi: a winning strategy for the race against evolving targets?
|
Mol Ther
|
2007
|
1.40
|
46
|
In vivo correction of murine tyrosinemia type I by DNA-mediated transposition.
|
Mol Ther
|
2002
|
1.39
|
47
|
Nonhomologous-end-joining factors regulate DNA repair fidelity during Sleeping Beauty element transposition in mammalian cells.
|
Mol Cell Biol
|
2003
|
1.37
|
48
|
Liver transduction with recombinant adeno-associated virus is primarily restricted by capsid serotype not vector genotype.
|
J Virol
|
2006
|
1.36
|
49
|
Immunogenicity and immunomodulatory properties of umbilical cord lining mesenchymal stem cells.
|
Cell Transplant
|
2010
|
1.36
|
50
|
The role of DNA-PKcs and artemis in opening viral DNA hairpin termini in various tissues in mice.
|
J Virol
|
2007
|
1.35
|
51
|
Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
|
J Clin Invest
|
2007
|
1.34
|
52
|
Capped small RNAs and MOV10 in human hepatitis delta virus replication.
|
Nat Struct Mol Biol
|
2008
|
1.34
|
53
|
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus.
|
J Clin Invest
|
2003
|
1.33
|
54
|
Silencing of hepatic fatty acid transporter protein 5 in vivo reverses diet-induced non-alcoholic fatty liver disease and improves hyperglycemia.
|
J Biol Chem
|
2008
|
1.32
|
55
|
The host response to adenovirus, helper-dependent adenovirus, and adeno-associated virus in mouse liver.
|
Mol Ther
|
2008
|
1.31
|
56
|
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors.
|
Nat Protoc
|
2010
|
1.30
|
57
|
Thermodynamic stability of small hairpin RNAs highly influences the loading process of different mammalian Argonautes.
|
Proc Natl Acad Sci U S A
|
2011
|
1.28
|
58
|
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
|
Am J Physiol Endocrinol Metab
|
2010
|
1.26
|
59
|
DNA palindromes with a modest arm length of greater, similar 20 base pairs are a significant target for recombinant adeno-associated virus vector integration in the liver, muscles, and heart in mice.
|
J Virol
|
2007
|
1.26
|
60
|
Molecular analysis of chromosomal rearrangements in mammalian cells after phiC31-mediated integration.
|
Hum Gene Ther
|
2006
|
1.25
|
61
|
Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level.
|
Mol Ther
|
2012
|
1.24
|
62
|
Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo.
|
Hum Gene Ther
|
2004
|
1.22
|
63
|
A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8.
|
Mol Ther
|
2007
|
1.19
|
64
|
A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo.
|
Blood
|
2002
|
1.18
|
65
|
How do miRNAs mediate translational repression?
|
Silence
|
2010
|
1.17
|
66
|
Postintegrative gene silencing within the Sleeping Beauty transposition system.
|
Mol Cell Biol
|
2007
|
1.15
|
67
|
Adeno-associated virus vectors for short hairpin RNA expression.
|
Methods Enzymol
|
2005
|
1.14
|
68
|
Liver tissue engineering at extrahepatic sites in mice as a potential new therapy for genetic liver diseases.
|
Hepatology
|
2005
|
1.14
|
69
|
Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
|
Circulation
|
2011
|
1.14
|
70
|
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles.
|
J Virol
|
2002
|
1.13
|
71
|
RNAi and gene therapy: a mutual attraction.
|
Hematology Am Soc Hematol Educ Program
|
2007
|
1.10
|
72
|
Low-level shRNA cytotoxicity can contribute to MYC-induced hepatocellular carcinoma in adult mice.
|
Mol Ther
|
2009
|
1.09
|
73
|
Helper-independent and AAV-ITR-independent chromosomal integration of double-stranded linear DNA vectors in mice.
|
Mol Ther
|
2003
|
1.08
|
74
|
Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I.
|
Mol Ther
|
2010
|
1.08
|
75
|
Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.
|
Blood
|
2006
|
1.08
|
76
|
Ribosomal DNA integrating rAAV-rDNA vectors allow for stable transgene expression.
|
Mol Ther
|
2012
|
1.08
|
77
|
Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.
|
J Virol
|
2003
|
1.06
|
78
|
A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro.
|
Mol Ther
|
2013
|
1.05
|
79
|
Radioprotection in vitro and in vivo by minicircle plasmid carrying the human manganese superoxide dismutase transgene.
|
Hum Gene Ther
|
2008
|
1.04
|
80
|
A direct comparison of two nonviral gene therapy vectors for somatic integration: in vivo evaluation of the bacteriophage integrase phiC31 and the Sleeping Beauty transposase.
|
Mol Ther
|
2005
|
1.04
|
81
|
Characterization of the relationship of AAV capsid domain swapping to liver transduction efficiency.
|
Mol Ther
|
2007
|
1.02
|
82
|
Pathways of removal of free DNA vector ends in normal and DNA-PKcs-deficient SCID mouse hepatocytes transduced with rAAV vectors.
|
Hum Gene Ther
|
2003
|
1.02
|
83
|
Looking into the safety of AAV vectors.
|
Nature
|
2003
|
1.02
|
84
|
Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo.
|
Hum Gene Ther
|
2005
|
1.01
|
85
|
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia.
|
Blood
|
2003
|
1.00
|
86
|
Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.
|
Mol Ther
|
2010
|
1.00
|
87
|
The extragenic spacer length between the 5' and 3' ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors.
|
Mol Ther
|
2012
|
0.98
|
88
|
A rapid protocol for construction and production of high-capacity adenoviral vectors.
|
Nat Protoc
|
2009
|
0.97
|
89
|
Slicing-independent RISC activation requires the argonaute PAZ domain.
|
Curr Biol
|
2012
|
0.96
|
90
|
Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.
|
RNA
|
2009
|
0.95
|
91
|
Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs.
|
Hum Gene Ther Clin Dev
|
2015
|
0.95
|
92
|
Free DNA ends are essential for concatemerization of synthetic double-stranded adeno-associated virus vector genomes transfected into mouse hepatocytes in vivo.
|
Mol Ther
|
2003
|
0.95
|
93
|
Expression determinants of mammalian argonaute proteins in mediating gene silencing.
|
Nucleic Acids Res
|
2011
|
0.95
|
94
|
The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo.
|
Mol Ther
|
2003
|
0.94
|
95
|
AAV vectors containing rDNA homology display increased chromosomal integration and transgene persistence.
|
Mol Ther
|
2012
|
0.93
|
96
|
Somatic integration from an adenoviral hybrid vector into a hot spot in mouse liver results in persistent transgene expression levels in vivo.
|
Mol Ther
|
2007
|
0.93
|
97
|
Optimization of cis-acting elements for gene expression from nonviral vectors in vivo.
|
Hum Gene Ther
|
2003
|
0.92
|
98
|
Advancing molecular therapies through in vivo bioluminescent imaging.
|
Mol Imaging
|
2003
|
0.92
|
99
|
An in vitro-identified high-affinity nucleosome-positioning signal is capable of transiently positioning a nucleosome in vivo.
|
Epigenetics Chromatin
|
2010
|
0.91
|
100
|
A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
|
Hepatology
|
2003
|
0.91
|
101
|
Gene transfer to mouse heart and skeletal muscles using a minicircle expressing human vascular endothelial growth factor.
|
J Cardiovasc Pharmacol
|
2009
|
0.91
|
102
|
Real-time in vivo imaging of stem cells following transgenesis by transposition.
|
Mol Ther
|
2005
|
0.89
|
103
|
Cis-acting gene regulatory activities in the terminal regions of sleeping beauty DNA transposon-based vectors.
|
Hum Gene Ther
|
2007
|
0.89
|
104
|
miR-122 continues to blaze the trail for microRNA therapeutics.
|
Mol Ther
|
2010
|
0.88
|
105
|
Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery.
|
Mol Ther
|
2007
|
0.88
|
106
|
Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo.
|
Hum Gene Ther
|
2002
|
0.88
|
107
|
MicroRNAs in Cancer: the 22nd Hiroshima Cancer Seminar/the 4th Japanese Association for RNA Interference Joint International Symposium, 30 August 2012, Grand Prince Hotel Hiroshima.
|
Jpn J Clin Oncol
|
2013
|
0.88
|
108
|
Wandering eye for RNAi.
|
Nat Med
|
2008
|
0.85
|
109
|
Donor-derived, liver-specific protein expression after bone marrow transplantation.
|
Transplantation
|
2004
|
0.84
|
110
|
Rapid and stable knockdown of an endogenous gene in retinal pigment epithelium.
|
Hum Gene Ther
|
2007
|
0.82
|
111
|
Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice.
|
Biotechnol Prog
|
2003
|
0.81
|
112
|
The expanding repertoire of circular RNAs.
|
Mol Ther
|
2013
|
0.81
|
113
|
rAAV-mediated tumorigenesis: still unresolved after an AAV assault.
|
Mol Ther
|
2012
|
0.81
|
114
|
Stability and repeat regeneration potential of the engineered liver tissues under the kidney capsule in mice.
|
Cell Transplant
|
2005
|
0.80
|
115
|
Hepatic parenchymal replacement in mice by transplanted allogeneic hepatocytes is facilitated by bone marrow transplantation and mediated by CD4 cells.
|
Hepatology
|
2008
|
0.79
|
116
|
Efficient inhibition of in-stent restenosis by controlled stent-based inhibition of elastase: a pilot study.
|
J Vasc Interv Radiol
|
2004
|
0.78
|
117
|
The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA.
|
Nucleic Acids Res
|
2013
|
0.78
|
118
|
Modified infusion procedures affect recombinant adeno-associated virus vector type 2 transduction in the liver.
|
Hum Gene Ther
|
2005
|
0.78
|
119
|
Translational Data from AAV-Mediated Gene Therapy of Hemophilia B in Dogs.
|
Hum Gene Ther Clin Dev
|
2014
|
0.77
|
120
|
System for simultaneous tissue-specific and disease-specific regulation of therapeutic gene expression.
|
Hum Gene Ther
|
2003
|
0.76
|
121
|
A story of mice and men.
|
Gene Ther
|
2002
|
0.76
|
122
|
Viral Vectors Take On HIV Infection.
|
N Engl J Med
|
2015
|
0.75
|
123
|
Characterization of vector-based delivery of neurogenin-3 in murine diabetes.
|
Hum Gene Ther
|
2014
|
0.75
|
124
|
Good news on the clinical gene transfer front.
|
Hum Gene Ther
|
2008
|
0.75
|
125
|
A Tribute to George Stamatoyannopoulos.
|
Hum Gene Ther
|
2016
|
0.75
|
126
|
Prime time for small RNA-based therapeutics.
|
Hum Gene Ther
|
2008
|
0.75
|